Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss

NCT02322099 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

53

Enrollment

OTHER

Sponsor class

Stopped Due to the COVID-19 pandemic the study was terminated prematurely

Conditions

Bone Demineralization

Interventions

DRUG: Alendronate
DRUG: Placebo
DIETARY_SUPPLEMENT: calcium carbonate and colecalciferol
DRUG: Tenofovir disoproxil

Sponsor

University College Dublin

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]